FDA issued a Warning Letter to SNBL USA LTD. on 8/9/2010 for a previous inspection.
483 Altasciences Preclinical Seattle Sep 2019

483 Altasciences Preclinical Seattle Sep 2019

Julian Hanson FDA, Hugh Mcclure FDA, Mark Seaton FDA$119.00 - Available Now

FDA investigators audited the Altasciences Preclinical Seattle - Everett, WA, United States facility and issued inspectional observations (via FDA 483) on 13 Sep 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Sep 2019
  • Location: Everett, United States
  • FEI: 3003199588
Add To Cart